Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What are you asking for it?
Agreed Seaheck. I am still on record saying we see several more offices open and revs will ramp up. I expected a 50% increase, not 20%, but its moving forward anyway you slice it.
Adding several more offices this year will significantly ramp of revs. Holding strong and will add when possible like always.
Nothing has changed, it is just rolling out slowly.
Yes it absolutely has been, and LONG overdue. Accumulation has been heavy and for good reason. Anyone following knows that revs will be up in Q2 and the next several Q's. Every day we get closer to seeing the efficacy trial, and we get closer to seeing more doctors added.
CaverStem and FemCelz are generating revs soon to be followed by StemSpine. CELZ is looking for a partner for AmnioStem. What about the other PATENTS?? Why TRADEMARK everything?
Folks, it is ALL right there for you to read up on. Do YOUR DD. DON'T believe ME or ANYONE on this board. READ up on the PATENTS!!! KNOW how many notes and warrants are left.
How many more doctors or offices have to be opened before the average trader sees this company for what it is? A small startup bio-tech with incredible PATENTS to back it up. They are working very hard, and very quietly which is NOT what the average OTC traders wants to see. Look at the forest between the trees!
When the average traders sees between the all the static and sees the potential here, and realizes they can buy in sub penny, the buying will increase significantly.
Watch the buys! They often go off between the bid/ask and tend to show up as sells here. Yesterday, HUGE buys showed up as sells. Evidence is right here, all facts. Make your own decisions. I clearly see accumulation underway for the inevitable breakout.
Not to mention the trading ticker software here is either full of shenanigans or is not robust. TWO BIG buys today, 10m and 13.5 million show up as sells when the other platforms show them as BUYS. Today’s volume should show 65 million in buys and 26 million sells. An entirely different view than JD and IHub are showing.
42M volume. Almost all buying. Being held down. easy to see
I don't have to, I will be living it :)
They just keep transferring from week hands to strong!
Smart, smart trader
Dilly Dilly. Exactly. Guaranteed to see an increase since there are several offices open now vs just LA previously. And your right, it’s a marathon not a sprint so many are used to in the OTC. These prices are embarrassingly low and an absolute steal.
8/14 is due date Tony
I agree DG10. IF CELZ was ever going to do an RS, they would have done it to save the QB rating. They did not, and that tells me they will not RS. There is no reason to at this point. TW holding so many street shares should give us comfort.
Not to mention, TW owns/controls enough shares that he would not RS his own shares, AND he has no fear of any takeover if the OS gets too high. His preferred shares control everything.
Offices will open this summer, the spark will be back here and we will get back over .01 soon enough. Then back to new highs. Since they already were on the QB, they can easily reapply and get the rating back. That’s why they have no worries, all IMHO
It will all come together as we wind down this year!
Part of the reason, IMO, is how many notes are converting. Buys vs Sells. Yesterday there were 35 million shares bought, but 25 million sold. If the buying percentage to selling was higher we would have went up more.
The other thing to consider, IMO, is the cash exchanging hands. 60 million in volume at .0015 is the same cash moving around as 30 million in volume at .003 or only 18 million in volume at .005. Volume numbers always go up when the PPS goes down.
If the notes dry up, and they will one day, and we see it and buying pressure hits, this will run fast. I hate this PPS in many ways, but I added 1.2 million shares yesterday. It’s a love hate relationship LOL
And, since our institutional investors are converting vs holding and letting the company breath, I am glad they are not getting sh** for their shares. If they held them and bled them out next year they would make a killing, but they are not being good partners IMO.
Agreed. They have filed two late notices since 2016. But who knows what’s going on behind the curtain? I bet it’s on time, but who knows for sure.
Great post sir
Since the doctors are all independent contractors just using a product, I recon it is up to them.
I think we are making a mountain out of a mole hill here. It’s not all or nothing, and it’s not a make or break moment if it’s not out end of the month. I don’t have time to dig it up, but it was my understanding that some of their claims are not from their trial, but other trials that have shown that stem cells simply help with ED. It been documented elsewhere already. They just patented their treatment version and also conducted their own trial.
Let’s be frank. It’s small, only 20 patients, and it’s short, only a year. It will be added information to the others who have conducted trials. They also conducted it on younger patients who where already shown to be not responding PED5 inhibitors. These guys were in tough shape. ANYTHING that can help them is an improvement. Good results are a win win because its not another DRUG or SURGERY. IMO, the trail results will be lower than what we have seen recently based on the patients. The ones in the trial who were difficult to begin with logically will have less gain. I think Gershman said 70%. Others like NM who are treating the average Joe and John are having better results because they are treating the average 50 something dude who has slowed up in the sack.
In its simplest form, it’s an injection. Not overly invasive now is it? And it’s NOT umbilical cord stem cells. They are your own, so there no need for FDA oversight and they are obviously safe.... nothing foreign. No crazy reactions etc. The “uncontrolled” stem cell guys we all fear are the ones using other folks stem cells or those derived from fat etc.
Let’s keep it even simpler. No one EVER said it is a 100% fix 100% of the time. It will not work on some, it will not be permanent on some. It is simply another big tool in the doctors toolbox that has great potential in helping folks without DRUGS or SURGERY. Every person helped in any way is a WIN we didn’t have before CaverStem.
Go back at listen to what Dr Narayan said in his video. It’s going to be a big deal. It’s needed.
My guess is that the 100 or so patients treated with CaverStem recently will be part of another bigger, longer trial. It’s a huge work in progress. This is just the beginning my friend.
It’s costing a ton of money to get this company up and running. The notes and warrants are not great. I have not seen one poster here say they are. But the bottom line is that the potential here is still awesome.
If CaverStem, FemCelz and StemSpine work out the kinks and get rolling like I think they will, these super low priced shares will pay off handsomely. It’s not a deal breaker one way or the other if the trial is published this month or not IMHO. They will get it out when they can because doctors want to see it too. And it’s not a deal breaker if there are more small notes. It’s the price of commercialization taking longer than everyone expected.
$CELZ.
What I am saying is the Gershman did the trial patients. He obviously knows how they did after the year(s).
Also take into consideration that these were younger, problematic difficult patients and he reported excellent results. They all know it. They have the info IMO.
All we are waiting on is the second opinion in all reality.
You and I both know they have the data, we both know the doctors have reviewed the data. We all know that it is in peer review that can be brutally slow. We all know they are working on it and it will be out when ready.
That is the track record with these guys. Build the patents and they will come!
Everyone know this is pounded down in the corner and we are just a few trading days away from what will obviously be their best Q. That will just be the start of the good news.
Added again :)
Same here. We know some of NM and Rome numbers didn’t clear the book in time to be seen in Q1. Add to that we know Liu and Narayan and Anderson all got up to speed in Q2.
Guaranteed to show growth. After 3 flat Q’s in a row, this will be the first of many that will show sustained growth.
I know a few folks waiting patiently on StemSpine. CELZ will have three rev streams by the years end IMO
I agree with .033. We were solid in that range for quite a while!
And we know the Q next week will show at least a good solid 50% increase in revs.
CELZ about to have a Rocky Balboa win.
Wait until the afternoon for me ;)
Yes it is!!
$80,000-$100,000 on the low end.
I could not agree more SCR!!
We've taken a number of steps that will help the world discover what we already know, regenerative medicine is the future of medicine and we'll help lead the charge.https://t.co/bhHiuoBOQY#health #biotechnology #womenshealth #stocks #investing #OTC $CELZ @CaverStem @femcelz pic.twitter.com/iwCdig163Q
— Creative Medical Technology Holdings, Inc. (@CMTH_Inc) August 5, 2019
Great link! NO SCAM here. Waiting on this one is not for the faint of heart. Anyone struggling needs to redo all of their DD. See the IP, see the patents, remember Medistem and WAIT.
Exactly. We will be looking good long before that, but be absolutely golden by then for sure!!!
No argument with you there. Like others have said, they have little control over the peer review timeline. My hunch is that they feel it will be out before the conference. It was not ready in the spring which is ONE reason they skipped the spring AUA. They know, or feel, or have reason to believe it will be out right around that one year mark. Whether that is August 31 when it ended, or in October 9 when the trial posted, I have no clue. Just my opinion.
https://clinicaltrials.gov/ct2/show/NCT03699943
They know the results. The participating doctors know the results. Just because the paper has not been issued doesn’t mean the data is not present.
What no one ever wants to talk about here is that the trial was conducted on younger, problematic patients and showed good results.
Imagine what it will do for the routine aging man with onset of ED who doesn’t want to risk the meds? Those results will be higher, just like NM is seeing.
You wouldn’t be attending if you didn’t have a product to present.
Well said DocPrep